University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments
University of Utah researchers have developed an enzyme technology that can stabilize and enhance therapeutic peptides for diabetes and obesity treatments, with the innovation now advancing toward clinical development through spinout company Sethera Therapeutics.
